









Markets
/
Stocks
/
nasdaq-lrtx
/

Lirum Therapeutics Ord Shs (Proposed)

LRTX

0.000

Close 12/24, 13:00（ET）Quotes delayed by 15 min

--Market Cap

--P/E TTM



Lirum Therapeutics Ord Shs (Proposed)

0.000

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

You can find the annual or quarterly income statement of Lirum Therapeutics Ord Shs (Proposed) here for insights into the performance and operational efficiency of Lirum Therapeutics Ord Shs (Proposed).

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2024Q1

FY2023Q4

FY2023Q1

FY2022Q4

Operating expenses

--739.34K

-83.72%298.20K

--583.55K

--1.83M

R&D expenses

--518.98K

-92.09%136.32K

--431.10K

--1.72M

Operating profit

---739.34K

83.72%-298.20K

---583.55K

---1.83M

Net non-operating interest income (expenses)

Income before tax

---739.34K

83.80%-298.20K

---589.76K

---1.84M

Income tax

--0.00

Income after tax

---739.34K

83.80%-298.20K

---589.76K

---1.84M

Net income from continuous operations

---739.34K

83.80%-298.20K

---589.76K

---1.84M

Net income attributable to controlling interests

---739.34K

83.80%-298.20K

---589.76K

---1.84M

Net income attributable to common shareholders

---739.34K

83.80%-298.20K

---589.76K

---1.84M

Basic earnings per share

---0.08

83.80%-0.03

---0.07

---0.20

Diluted earnings per share

---0.08

83.80%-0.03

---0.07

---0.20

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

